Identification of ferroptosis as a novel mechanism for antitumor activity of natural product derivative a2 in gastric cancer

Autor: Zan Song, De-Quan Yu, Hong-Min Liu, Wang Wang, Yu Ke, Xu-Bin Ma, Ying Liu, Yajie Liu, Yi-Chao Xu
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Programmed cell death
DCFH-DA
dichlorodihydro-fluorescein diacetate

qRT-PCR
quantitative real time PCR

NAC
N-acetylcysteine

RM1-950
GPX4
KEGG
Kyoto Encyclopedia of Genes and Genomes

PK
pharmacokinetic

Lipid peroxidation
Papp
apparent permeability coefficient

03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
ROS
reactive oxygen species

Downregulation and upregulation
medicine
Autophagy
Ferroptosis
PDX
patient-derived tumor xenograft

RTV
relative tumor volume

General Pharmacology
Toxicology and Pharmaceutics

JDA
Jiyuan oridonin A

PARP
poly ADP-ribose polymerase

030304 developmental biology
0303 health sciences
Cell growth
Jiyuan Rabdosia rubescens
Cancer
ROS
medicine.disease
Verp
verapamil

DCM
dichloromethane

chemistry
IKE
imidazole ketone erastin

JDA derivative
030220 oncology & carcinogenesis
Cancer cell
CDX
cell line-derived xenograft

Cancer research
Ferrous iron
Original Article
5-FU
5-fluorouracil

Therapeutics. Pharmacology
Gastric cancer
Zdroj: Acta Pharmaceutica Sinica B, Vol 11, Iss 6, Pp 1513-1525 (2021)
Acta Pharmaceutica Sinica. B
ISSN: 2211-3835
Popis: Ferroptosis is a type of cell death accompanied by iron-dependent lipid peroxidation, thus stimulating ferroptosis may be a potential strategy for treating gastric cancer, therapeutic agents against which are urgently required. Jiyuan oridonin A (JDA) is a natural compound isolated from Jiyuan Rabdosia rubescens with anti-tumor activity, unclear anti-tumor mechanisms and limited water solubility hamper its clinical application. Here, we showed a2, a new JDA derivative, inhibited the growth of gastric cancer cells. Subsequently, we discovered for the first time that a2 induced ferroptosis. Importantly, compound a2 decreased GPX4 expression and overexpressing GPX4 antagonized the anti-proliferative activity of a2. Furthermore, we demonstrated that a2 caused ferrous iron accumulation through the autophagy pathway, prevention of which rescued a2 induced ferrous iron elevation and cell growth inhibition. Moreover, a2 exhibited more potent anti-cancer activity than 5-fluorouracil in gastric cancer cell line-derived xenograft mice models. Patient-derived tumor xenograft models from different patients displayed varied sensitivity to a2, and GPX4 downregulation indicated the sensitivity of tumors to a2. Finally, a2 exhibited well pharmacokinetic characteristics. Overall, our data suggest that inducing ferroptosis is the major mechanism mediating anti-tumor activity of a2, and a2 will hopefully serve as a promising compound for gastric cancer treatment.
Graphical abstract Natural product derivative, a2, exhibited anti-tumor activity by inducing ferroptosis through decreasing GPX4 and causing ferrous iron accumulation in gastric cancer cells.Image 1
Databáze: OpenAIRE